MedTrace Logo

The COPD Attack Study

NCT05779384 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 323

Last updated 2023-03-22

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the frequency and predictors of exacerbations in COPD patient population in Uganda.

The main questions it aims to answer are:-

1. What is the proportion of frequent exacerbators (≥2/year) and what factors are associated with the frequent exacerbator phenotype?
2. What is the frequency of exacerbations and what factors are correlated with exacerbation frequency? Participants will be asked to offer demographic ,clinical and exposure questions. Questionnaires assessing disease burden, and quality of life will be administered. Clinical measurements, and complete blood count will be collected ta baseline and on sick visits. Spirometry will be measured at baseline and on the last visit. Samples will be collected for storage. Participants will be followed up for one year.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Exacerbation COPD

Interventions

OTHER

It was an observational study

data collected concerning the incidence of exacerbations

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University College, London

    collaborator OTHER

  • Makerere University

    lead OTHER

Principal Investigators

Eligibility

Min Age
30 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-07
Primary Completion
2021-03-30
Completion
2021-03-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05779384 on ClinicalTrials.gov